VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 588 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2015. The put-call ratio across all filers is 2.30 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $586,000 | -85.8% | 3,300 | -82.3% | 0.01% | -84.2% |
| Q2 2015 | $4,128,000 | +18.7% | 18,600 | +5.7% | 0.04% | +18.8% |
| Q1 2015 | $3,477,000 | -74.8% | 17,600 | -81.7% | 0.03% | -74.8% |
| Q4 2014 | $13,815,000 | +37.1% | 96,200 | +25.8% | 0.13% | +15.5% |
| Q1 2014 | $10,075,000 | +3078.2% | 76,456 | +2731.7% | 0.11% | +2650.0% |
| Q4 2013 | $317,000 | +12.4% | 2,700 | 0.0% | 0.00% | +33.3% |
| Q3 2013 | $282,000 | +21.6% | 2,700 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $232,000 | – | 2,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,586,582 | $864,160,000 | 32.02% |
| FARLEY CAPITAL L.P. | 341,518 | $44,807,000 | 30.12% |
| LeVasseur Capital Partners LLC | 190,404 | $24,981,000 | 29.94% |
| Ruane, Cunniff & Goldfarb | 34,494,015 | $4,525,615,000 | 23.97% |
| ValueAct Holdings | 18,923,877 | $2,482,813,000 | 16.64% |
| White River Investment Partners, LLC | 90,099 | $11,820,000 | 16.35% |
| Tesuji Partners | 1,368,040 | $179,487,000 | 15.45% |
| Arrow Capital Management, LLC | 197,500 | $25,912,000 | 15.11% |
| Hound Partners | 3,576,998 | $469,302,000 | 14.87% |
| Brahman Capital Corp. | 4,457,153 | $584,778,000 | 12.82% |